PHR
Undervalued by 44.3% based on the discounted cash flow analysis.
Market cap | $1.15 Billion |
---|---|
Enterprise Value | $1.08 Billion |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $-2.51 |
Beta | 0.0 |
Outstanding Shares | 56,387,472 |
Avg 30 Day Volume | 466,906 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -8.43 |
---|---|
PEG | 43.45 |
Price to Sales | 3.44 |
Price to Book Ratio | 5.15 |
Enterprise Value to Revenue | 3.03 |
Enterprise Value to EBIT | -7.9 |
Enterprise Value to Net Income | -8 |
Total Debt to Enterprise | 0.01 |
Debt to Equity | 0.05 |
No data
No data
Phreesia gives healthcare organizations a suite of robust applications to manage the patient intake process. Our innovative SaaS platform engages patients and provides a modern, convenient experience, while enabling our clients to optimi...